Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

Kadoaki Ohashi, Lecia V. Sequist, Maria E. Arcila, Teresa Moran, Juliann Chmielecki, Ya Lun Lin, Yumei Pan, Lu Wang, Elisa De Stanchina, Kazuhiko Shien, Keisuke Aoe, Shinichi Toyooka, Katsuyuki Kiura, Lynnette Fernandez-Cuesta, Panos Fidias, James Chih Hsin Yang, Vincent A. Miller, Gregory J. Riely, Mark G. Kris, Jeffrey A. EngelmanCindy L. Vnencak-Jones, Dora Dias-Santagata, Marc Ladanyi, William Pao

Research output: Contribution to journalArticlepeer-review

348 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1'. Together they form a unique fingerprint.

Medicine & Life Sciences